Results 171 to 180 of about 7,988 (196)
Some of the next articles are maybe not open access.

Neurotoxicity of immunotoxins

Molecular and chemical neuropathology, 1994
Immunotoxins are being tested for the therapy of systemic cancer and brain tumors. Neurotoxicity has been dose limiting for several of these antibody conjugates given systemically. We review the animal and clinical data related to the neurotoxicity of immunotoxins in attempt to understand the molecular basis for the unexpected neural involvement and to
O, Ilercil   +5 more
openaire   +2 more sources

[Immunotoxins].

Bulletin du cancer, 1983
Immunotoxins are conjugates between antibodies especially directed against cancer cells and a subunit of a powerful toxin. We used the A-chain of ricin. These conjugates are specifically cytotoxic when used at very low concentrations in vitro and can destroy more than 99.99% of clonogenic cells.
F K, Jansen   +13 more
openaire   +1 more source

Pseudomonas exotoxin — Immunotoxins

1988
Monoclonal antibodies can be coupled with PE to make very potent ITs. Two of these ITs (PE-HB21 and OVB-3-PE) have been shown to have antitumor activity in a nude mouse model of ovarian cancer. PE ITs are at least 10-fold more active than the corresponding RTA IT.
D J, FitzGerald   +2 more
openaire   +2 more sources

Immunotoxins

1997
Abstract Immunotoxins (ITs) are cell type-specific cytotoxic agents consisting of an antibody linked to a protein toxin. The antibody component is responsible for directing the toxin selectively to the target cell and the toxin component is responsible for killing the cell (for reviews on ITs see refs 1—5).
Elaine J Derbyshire   +2 more
openaire   +1 more source

Immunotoxins containing ricin

1988
Bacterial and plant toxins composed of different protein subunits with diverse biological functions have provided an investigational focal point for researchers in many areas of specialization. Potent catalytic toxins have been linked to monoclonal antibodies (MoAb) for antibody directed cell targeting.
D A, Vallera, D E, Myers
openaire   +2 more sources

Immunotoxins

Cell, 1986
I, Pastan   +2 more
openaire   +2 more sources

Immunotoxins

Scientific American, 1984
R J, Collier, D A, Kaplan
openaire   +2 more sources

Immunotoxins and Recombinant Immunotoxins in Cancer Therapy

2006
Targeted cancer therapy in general and immunotherapy in particular, combines rational drug design with the progress in understanding cancer biology. This approach takes advantage of our recent knowledge of the mechanisms by which normal cells are transformed into cancer cells, thus, using the special properties of cancer cells to device novel ...
Yoram Reiter, Avital Lev
openaire   +1 more source

Immunotoxins

Clinical Immunotherapeutics, 1994
openaire   +2 more sources

Home - About - Disclaimer - Privacy